Abstract:BACKGROUND & AIMS: Visceral smooth muscle cells (SMCs) are an integral component of the gastrointestinal (GI) tract that regulate GI motility. SMC contraction is regulated by post-translational signaling and the state of differentiation. Impaired SMC contraction is associated with significant morbidity and mortality, but the mechanisms regulating SMC-specific contractile gene expression, including the role of long noncoding RNAs (lncRNAs), remain largely unexplored. Herein, we reveal a critical role of Carmn (cardiac mesoderm enhancer-associated noncoding RNA), an SMC-specific lncRNA, in regulating visceral SMC phenotype and contractility of the GI tract. METHODS: Genotype-Tissue Expression and publicly available single-cell RNA sequencing (scRNA-seq) data sets from embryonic, adult human, and mouse GI tissues were interrogated to identify SMC-specific lncRNAs. The functional role of Carmn was investigated using novel green fluorescent protein (GFP) knock-in (KI) reporter/knock-out (KO) mice. Bulk RNA-seq and single nucleus RNA sequencing (snRNA-seq) of colonic muscularis were used to investigate underlying mechanisms. RESULTS: Unbiased in silico analyses and GFP expression patterns in Carmn GFP KI mice revealed that Carmn is highly expressed in GI SMCs in humans and mice. Premature lethality was observed in global Carmn KO and inducible SMC-specific KO mice due to GI pseudo-obstruction and severe distension of the GI tract, with dysmotility in cecum and colon segments. Histology, GI transit, and muscle myography analysis revealed severe dilation, significantly delayed GI transit, and impaired GI contractility in Carmn KO vs control mice. Bulk RNA-seq of GI muscularis revealed that loss of Carmn promotes SMC pheno-typic switching, as evidenced by up-regulation of extracellular matrix genes and down-regulation of SMC contractile genes, including Mylk, a key regulator of SMC contraction. snRNA-seq further revealed SMC Carmn KO not only compromised myogenic motility by reducing contractile gene expression but also impaired neurogenic motility by disrupting cell-cell con-nectivity in the colonic muscularis. These findings may have translational significance, because silencing CARMN in human colonic SMCs significantly attenuated contractile gene expres-sion, including MYLK, and decreased SMC contractility. Lucif-erase reporter assays showed that CARMN enhances the transactivation activity of the master regulator of SMC contractile phenotype, myocardin, thereby maintaining the GI SMC myogenic program. CONCLUSIONS: Our data suggest that Carmn is indispensable for maintaining GI SMC contractile function in mice and that loss of function of CARMN may contribute to human visceral myopathy. To our knowledge this is the first study showing an essential role of lncRNA in the regulation of visceral SMC phenotype.

Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease

The Long Noncoding RNA Cardiac Mesoderm Enhancer- Associated Noncoding RNA (carmn) is a Critical Regulator of Gastrointestinal Smooth Muscle Contractile Function and Motility

CARMN is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin

Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression

Exploring the multifaceted role of GCN1: Implications in cellular responses and disease pathogenesis

Cosmc transfection decreases malignant behavior of Tn+ cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure

The Cosmc connection to the Tn antigen in cancer

The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity

Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance

Cosmc regulates O-glycan extension in murine hepatocytes

The Role of Chaperone-Mediated Autophagy in Tissue Homeostasis and Disease Pathogenesis

Revisiting the chaperonin T‐complex protein‐1 ring complex in human health and disease: A proteostasis modulator and beyond

Germline C1GALT1C1 mutation causes a multisystem chaperonopathy

Emerging Role of GCN1 in Disease and Homeostasis

CARMA3: A potential therapeutic target in non-cancer diseases

Chaperone-mediated autophagy: Molecular mechanisms, biological functions, and diseases

Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A

The ESCRT protein CHMP5 controls skeletal muscle homeostasis and coordinates myeloid cell-mediated tissue repair

Molecular Chaperones: Molecular Assembly Line Brings Metabolism and Immunity in Shape

The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers

Chaperone-Mediated Autophagy Regulates Hypoxic Pathology in Cardiomyocytes